Kazia Therapeutics (KZIA) Institutional Ownership $3.43 -0.11 (-3.11%) Closing price 05/21/2025 03:51 PM EasternExtended Trading$3.49 +0.06 (+1.72%) As of 05/21/2025 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Kazia Therapeutics (NASDAQ:KZIA)CurrentInstitutional OwnershipPercentage30.89%Number ofInstitutional Buyers(last 12 months)2TotalInstitutional Inflows(last 12 months)$30.38MNumber ofInstitutional Sellers(last 12 months)0 Get KZIA Insider Trade Alerts Want to know when executives and insiders are buying or selling Kazia Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data KZIA Institutional Buying and Selling by Quarter Kazia Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/13/2025 Barclays PLC120,000$212K0.0%N/A2.381% 11/7/2024 MAI Capital Management1,363,894$586K0.0%N/A51.663% 2/14/2024 Platinum Investment Management Ltd.1,821,887$801K0.0%N/A11.150% 2/13/2024 Armistice Capital LLC2,475,555$1.09M0.0%N/A15.150% 3/6/2023 OLD Mission Capital LLC42,765$26K0.0%-47.2%0.308% 11/14/2022 OLD Mission Capital LLC80,923$89K0.0%N/A0.583% 7/29/2022 SG Americas Securities LLC13,988$59K0.0%-41.5%0.106% 4/29/2022 SG Americas Securities LLC23,899$184K0.0%-29.9%0.181% 2/7/2022 SG Americas Securities LLC34,106$288K0.0%-14.3%0.258% 2/4/2022 Envestnet Asset Management Inc.26,412$223K0.0%N/A0.200% 11/1/2021 SG Americas Securities LLC39,776$450K0.0%-10.4%0.301% 10/21/2021 Total Clarity Wealth Management Inc.4,755$54K0.0%N/A0.036% 8/13/2021 Renaissance Technologies LLC65,823$649K0.0%+188.2%0.508% 8/12/2021 SG Americas Securities LLC44,398$438K0.0%+12.1%0.343% 5/18/2021 Morgan Stanley230,801$2.86M0.0%+28.5%1.781% 5/13/2021 SG Americas Securities LLC39,616$491K0.0%N/A0.419% 5/13/2021 Renaissance Technologies LLC22,840$283K0.0%-71.3%0.241% (Data available from 1/1/2016 forward) KZIA Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of KZIA shares? During the previous two years, the following institutional investors and hedge funds held shares of Kazia Therapeutics shares: Armistice Capital LLC ($1.09M), Platinum Investment Management Ltd. ($801K), and MAI Capital Management ($586K), Barclays PLC ($212K).Learn more on KZIA's institutional investors. What percentage of Kazia Therapeutics stock is owned by institutional investors? 30.89% of Kazia Therapeutics stock is owned by institutional investors. Learn more on KZIA's institutional investor holdings. Which institutional investors have been buying Kazia Therapeutics stock? The following institutional investors have purchased Kazia Therapeutics stock in the last 24 months: Armistice Capital LLC ($2.48M), Platinum Investment Management Ltd. ($1.82M), MAI Capital Management ($1.36M), and Barclays PLC ($120K). How much institutional buying is happening at Kazia Therapeutics? Institutional investors have bought a total of 5,781,336 shares in the last 24 months. This purchase volume represents approximately $124.82M in transactions. Related Companies GOVX Major Shareholders EQ Major Shareholders EDSA Major Shareholders LPTX Major Shareholders MEIP Major Shareholders PRPH Major Shareholders GELS Major Shareholders ME Major Shareholders RLMD Major Shareholders TRIB Major Shareholders This page (NASDAQ:KZIA) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredA new financial chapter Porter Stansberry says what happened last week could become the defining legacy of his financial publishing ca...Porter & Company | SponsoredThe Secret Map of America, Declassified…Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...Banyan Hill Publishing | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredElon’s backup plan for AIElon knows the future isn’t about smarter AI — it’s about powering it. And this new technology is quietly b...True Market Insiders | SponsoredExclusive Offer: Target 100% Returns NowBrace yourself–this may come as a shock. It turns out that you may not have to wait decades to turn a small...ProsperityPub | SponsoredPrepare now for May 31 eventPrepare now for May 31 event Circle May 31 on your calendar This man grew up in a trailer in New Mexico. To...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kazia Therapeutics Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Kazia Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
